1801 - 1810 of 7942 Results
Title
Year
- Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity2022OPENTitle: Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase ActivityJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 5Start Page: 1423End Page: 1447Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-213128Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd213128?id=journal-of-parkinsons-disease%2Fjpd213128Citation Count: 12
-
OPENTitle: Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 2Start Page: 255End Page: 269Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26410Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329215Citation Count: 13
- Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study2022OPENTitle: Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot StudyJournal Name: Brain SciencesPublisher: MDPI AGVol: 12Issue #: 5Start Page: 661End Page: 661Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci12050661Best OA location URL: https://www.mdpi.com/2076-3425/12/5/661/pdf?version=1652942510Citation Count: 6
- Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's disease2022RESTRICTEDTitle: Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 99Issue #:Start Page: 58End Page: 61Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.010Citation Count: 11
-
RESTRICTEDTitle: Personalized Care in Late-Stage Parkinson’s Disease: Challenges and OpportunitiesJournal Name: Journal of Personalized MedicinePublisher: MDPI AGVol: 12Issue #: 5Start Page: 813End Page: 813Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/jpm12050813Best OA location URL: https://www.mdpi.com/2075-4426/12/5/813/pdf?version=1652864161Citation Count: 4
-
RESTRICTEDTitle: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1346End Page: 1359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29058Citation Count: 14
-
RESTRICTEDTitle: Symptomatic Care in Multiple System Atrophy: State of the ArtJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 22Issue #: 3Start Page: 433End Page: 446Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-022-01411-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-022-01411-6.pdfCitation Count: 7
- Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review2022OPENTitle: Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature ReviewJournal Name: DystoniaPublisher: Frontiers Media SAVol: 1Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/dyst.2022.10359Best OA location URL: https://www.frontierspartnerships.org/articles/10.3389/dyst.2022.10359/pdfCitation Count: 21
-
OPENTitle: Combining biomarkers for prognostic modelling of Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 93Issue #: 7Start Page: 707End Page: 715Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2021-328365Best OA location URL: https://jnnp.bmj.com/content/jnnp/93/7/707.full.pdfCitation Count: 16
- Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study2022OPENTitle: Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab StudyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 6Start Page: 751End Page: 758Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13471Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13471Citation Count: 17